Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

TELESTA THERAPEUTICS INC > Could bounce back to 0.15 - 0.20..T.TST..$$$$
View:
Post by leaf67 on Feb 10, 2016 3:01pm

Could bounce back to 0.15 - 0.20..T.TST..$$$$

Momentum building here and it could easily gap up nicely tomorrow and run upwards to the 0.20 range short term. Do your own dd before buying any stock. Leaf67
Comment by kersmash on Feb 10, 2016 3:40pm
Oh great leaf67 is here...never ends well when he comes lurking around :(
Comment by kersmash on Feb 10, 2016 3:42pm
Still 5 starring yourself and still using the same OLD lines hahaha at least get some new material man..its 2016 
Comment by biloshi on Feb 11, 2016 2:44am
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

Dealroom for high-potential pre-IPO opportunities